TVRDTvardi Therapeutics Inc. Common Stock
1.860USD-1.06%Mkt Cap: 24.81M $P/E: —3d ago
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap24.81M $
Enterprise Value-6.98M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-18.21M $
Revenue/Share—
Last Price1.860 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees12
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.81
PEG—
EV/EBITDA0.24
EV/Revenue—
P/S—
P/B1.18
EPS (TTM)-2.79
EPS (Forward)-2.27
52W Range
1.5001% of range43.65
52W High43.65 USD
52W Low1.500 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-86.96%
ROA-56.79%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-23.50M $
CapEx (TTM)—
FCF Margin—
FCF Yield-46.63%
Net Debt-24.81M $
Net Debt/EBITDA0.85
Balance Sheet
Debt/Equity0.01
Current Ratio2.25
Quick Ratio2.22
Book Value/Sh1.546 USD
Cash/Share2.663 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:3
Split DateApr 16, 2025
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)8.500 USD
Upside (mean)+357.0%
Target Range3.000 USD – 13.00 USD
$3.000+357.0% to mean$13.00
# Analysts8
Ownership
Shares Out.13.34M
Float5.67M
Insiders26.02%
Institutions18.54%
Short Interest
Short Ratio0.0d
Short % Float2.11%
Short % Out.2.10%
Shares Short262.48K
Short (prev mo.)507.43K
Technical
SMA 502.432 (-23.5%)
SMA 2003.451 (-46.1%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)924.05K
Avg Vol (10d)190.41K
Technical Indicators
RSI (14)37.4
MACD-0.2151
MACD Signal-0.2253
MACD Hist.+0.0102
BB Upper2.578 USD
BB Middle2.037 USD
BB Lower1.495 USD
BB Width53.17%
ATR (14)0.2308 USD
Vol Ratio (20d)0.44x